Qube Research & Technologies LTD Arrowhead Pharmaceuticals, Inc. Transaction History

Qube Research & Technologies LTD

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$9.99 - $16.97 $853,505 - $1.45 Million	-85,436 Reduced 64.68%	46,659 $737,000
Q1 2025 May 15, 2025	BUY	$12.74 - $21.53 $168,320 - $284,454	13,212 Added 11.11%	132,095 $1.68 Million
Q4 2024 Feb 14, 2025	BUY	$17.7 - $26.34 $681,927 - $1.01 Million	38,527 Added 47.95%	118,883 $2.24 Million
Q3 2024 Nov 14, 2024	BUY	$19.36 - $29.54 $1.56 Million - $2.37 Million	80,356 New	80,356 $1.56 Million
Q3 2023 Nov 13, 2023	BUY	$26.2 - $36.08 $929,130 - $1.28 Million	35,463 Added 98.25%	71,558 $1.92 Million

Q2 2023 Aug 14, 2023	SELL	$25.16 - $41.38 $315,078 - $518,201	-12,523 Reduced 25.76%	36,095 $1.29 Million
Q1 2023 May 15, 2023	BUY	$23.68 - $38.51 $1.15 Million - $1.87 Million	48,618 New	48,618 $1.23 Million
Q2 2022 Aug 15, 2022	SELL	$27.79 - $50.61 $320,307 - $583,330	-11,526 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$39.62 - $69.97 $456,660 - $806,474	11,526 New	11,526 $530,000
Q3 2021 Nov 12, 2021	SELL	$58.38 - $84.96 $1.37 Million - $2 Million	-23,520 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$62.15 - $90.32 $1.46 Million - $2.12 Million	23,520 New	23,520 $1.95 Million
Q1 2020 May 15, 2020	SELL	$20.56 - $63.12 $110,139 - $338,133	-5,357 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$28.14 - $73.01 $150,745 - $391,114	5,357 New	5,357 $340,000

339

103M

953K

263K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $4.37B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.